EMA’s Risk-Based GMP Inspection Planning

digi — Sat, 07 Jun 2025 20:38:53 +0000

EMA’s Risk-Based GMP Inspection Planning How EMA Applies Risk-Based Planning for GMP Inspections in the EU The European Medicines Agency (EMA), together with the national competent authorities (NCAs) of EU Member States, uses a sophisticated risk-based approach to plan and conduct GMP inspections. This strategy ensures efficient allocation of resources while maintaining robust oversight of...

EMA site risk factors – Pharma GMP

EMA’s Risk-Based GMP Inspection Planning